Investors in Health Care

Eclosion assists entrepreneurs with the necessary resources to bridge the gap between their laboratories and the stage where the start-up

At Lauxera Capital Partners, we are an independent, international asset management company focused on healthcare. Our expertise lies in growth equity investments, particularly in commercial-stage medical devices, digital health, life sciences tools, and healthcare data companies. Led by entrepreneurial company builders and seasoned healthcare investors with extensive experience across international markets, we empower European healthtech entrepreneurs to realize the growth potential of their innovations.

Catapult Ventures is led by some of the most experienced venture capital investors in the UK. Our team's expertise spans diverse sectors including healthcare, pharmaceuticals, luxury consumer brands, manufacturing, and software. We engage across all stages of company growth, from supporting startups and pre-revenue IP developers to managing company floatations and overseeing billions of pounds in revenue. At Catapult Ventures, we prioritize value creation through long-term relationships with both our portfolio companies and the investors in our managed funds. Each member of our executive team holds direct portfolio responsibility, actively serving as board members who shape investee company strategies, contribute to senior personnel hires, and sometimes even facilitate customer engagements. Our executives are integral to financial strategy, leveraging banking relationships and introducing new investors for additional funding rounds as needed. As an independent fund manager, Catapult Ventures has successfully operated numerous discrete venture capital funds on behalf of a range of public and private sector investors, totaling approximately £130 million.

Esperante, a corporate venture capital firm affiliated with a global life science group, boasts leadership with deep operational expertise in the development, manufacturing, and global marketing of prescription pharmaceuticals and in vitro clinical diagnostic tests. Since its establishment in 2004, Esperante has strategically invested in 24 pharmaceutical and diagnostic companies across the US, UK, continental Europe, and Israel. Notably, the firm has achieved three successful exits: Thiakis to Wyeth/Pfizer, Pinnacle Biologics to Concordia, and Haemostatix to Ergomed. Currently, four portfolio companies are publicly listed in the US, Canada, and UK, with a focus on therapeutics in advanced clinical stages and diagnostics companies entering the European market. Esperante pursues initial investments of up to EUR 2,000,000 per venture in collaboration with other investors, aiming for exits through sales or liquidity events within a three-year timeframe.

XO Ventures is a venture capital investment firm based in the heart of Silicon Valley, specializing in early-stage technology startups. With a focus on disruptive innovations, XO Ventures provides strategic capital and mentorship to entrepreneurs across various sectors including AI, biotech, and fintech. Their team of experienced investors and advisors supports startups through the critical phases of growth, aiming to accelerate their development and market entry. XO Ventures is committed to fostering innovation and driving forward groundbreaking technologies that have the

We provide comprehensive support to (starting, growing) companies with a technological or marketing background. We work together on reaching growth targets and provide an infrastructure of knowledge and support where the management can tip into. This includes marketing, Financial, legal and human resource support.

DOMiNO Ventures is a venture capital firm focused on investing in early-stage technology startups across Europe and North America. Founded with a mission to support innovative entrepreneurs, DOMiNO Ventures provides seed and early-stage funding to companies with disruptive technologies and scalable business models. The firm targets sectors such as software, digital media, artificial intelligence, cybersecurity, and other emerging technologies. DOMiNO Ventures aims to identify promising startups and help them achieve rapid growth through strategic investment and operational support. Beyond capital infusion, DOMiNO Ventures actively engages with portfolio companies, offering mentorship, access to networks, and guidance in areas crucial for scaling, such as market expansion and product development. This hands-on approach is designed to maximize the potential of early-stage ventures and enhance their competitiveness in the global marketplace. DOMiNO Ventures is known for its agile investment strategy and flexibility in adapting to the evolving needs of startups, aiming to create long-term value for both entrepreneurs and investors.

Vang Capital operates as an early-stage, high-risk investment fund. Specializing in supporting innovative ventures, Vang Capital focuses on identifying and nurturing promising startups with high growth potential. Their investment strategy aims to provide strategic capital and operational support to help startups navigate early-stage challenges and achieve significant market traction. Vang Capital's commitment to fostering innovation and entrepreneurship underscores their role in driving forward transformative ideas and technologies.

Praesidium was founded in 2016 by a group of highly experienced European and American professionals from international Private Equity, consulting and banking, with a shared vision to create a truly innovative model for successfully investing "thematically" in Private Markets.

SCVC (Science Creates Venture Capital) specializes in investing in advanced technologies ranging from biotech to quantum tech. They partner with companies that share their mission of enhancing global health and sustainability. As a team of deep tech enthusiasts and serial entrepreneurs, SCVC supports like-minded founders who are driven to make a significant impact. Operating as the official VC arm of Science Creates, SCVC provides access to a specialized ecosystem encompassing incubators, investment opportunities, strategic partnerships, and tailored programs tailored for deep tech startups. Their focus is on nurturing innovation and accelerating the growth of technologies that address critical global challenges.

Széchenyi Funds Ltd. has been the leading capital financing partner for Hungarian SMEs and large companies since 2011, managing over HUF 155 billion in capital through its investment programs. With more than 130 successful investments and 50+ profitable exits, the fund manager focuses on companies with promising growth potential in Central and Eastern Europe, aiming for profitable exits after fostering long-term growth. The investment team, consisting of seasoned experts, provides comprehensive support to portfolio companies, ensuring that financing is never an obstacle to success.

Cognitive Corporate Finance is a cutting-edge, technology-enhanced, Big Data-powered third millennium merchant advisory firm Through an intimate knowledge of investors’ needs, as well as through unparalleled contacts, we bring our clients the most relevant advice, the optimal financial solution and the best and fastest service in finding capital or strategic partners for their corporate requirements